866-997-4948(US-Canada Toll Free)

United States High Potency API Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 115 Pages

Notes:
Sales, means the sales volume of High Potency API
Revenue, means the sales value of High Potency API

This report studies sales (consumption) of High Potency API in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Mylan

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Synthetic HPAPIs
Biotech HPAPIs
Split by applications, this report focuses on sales, market share and growth rate of High Potency API in each application, can be divided into
Oncology
Hormonal Disorders
Glaucoma
Other

Table of Contents

United States High Potency API Market Report 2017
1 High Potency API Overview
1.1 Product Overview and Scope of High Potency API
1.2 Classification of High Potency API
1.2.1 Synthetic HPAPIs
1.2.2 Biotech HPAPIs
1.3 Application of High Potency API
1.3.1 Oncology
1.3.2 Hormonal Disorders
1.3.3 Glaucoma
1.3.4 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of High Potency API (2012-2022)
1.4.1 United States High Potency API Sales and Growth Rate (2012-2022)
1.4.2 United States High Potency API Revenue and Growth Rate (2012-2022)

2 United States High Potency API Competition by Manufacturers
2.1 United States High Potency API Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States High Potency API Revenue and Share by Manufactures (2015 and 2016)
2.3 United States High Potency API Average Price by Manufactures (2015 and 2016)
2.4 High Potency API Market Competitive Situation and Trends
2.4.1 High Potency API Market Concentration Rate
2.4.2 High Potency API Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States High Potency API Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States High Potency API Sales and Market Share by States (2012-2017)
3.2 United States High Potency API Revenue and Market Share by States (2012-2017)
3.3 United States High Potency API Price by States (2012-2017)

4 United States High Potency API Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States High Potency API Sales and Market Share by Type (2012-2017)
4.2 United States High Potency API Revenue and Market Share by Type (2012-2017)
4.3 United States High Potency API Price by Type (2012-2017)
4.4 United States High Potency API Sales Growth Rate by Type (2012-2017)

5 United States High Potency API Sales (Volume) by Application (2012-2017)
5.1 United States High Potency API Sales and Market Share by Application (2012-2017)
5.2 United States High Potency API Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States High Potency API Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 High Potency API Product Type, Application and Specification
6.1.2.1 Synthetic HPAPIs
6.1.2.2 Biotech HPAPIs
6.1.3 Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis International
6.2.2 High Potency API Product Type, Application and Specification
6.2.2.1 Synthetic HPAPIs
6.2.2.2 Biotech HPAPIs
6.2.3 Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 High Potency API Product Type, Application and Specification
6.3.2.1 Synthetic HPAPIs
6.3.2.2 Biotech HPAPIs
6.3.3 Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
6.4.2 High Potency API Product Type, Application and Specification
6.4.2.1 Synthetic HPAPIs
6.4.2.2 Biotech HPAPIs
6.4.3 Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 High Potency API Product Type, Application and Specification
6.5.2.1 Synthetic HPAPIs
6.5.2.2 Biotech HPAPIs
6.5.3 Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.2 High Potency API Product Type, Application and Specification
6.6.2.1 Synthetic HPAPIs
6.6.2.2 Biotech HPAPIs
6.6.3 Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
6.7.2 High Potency API Product Type, Application and Specification
6.7.2.1 Synthetic HPAPIs
6.7.2.2 Biotech HPAPIs
6.7.3 Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 High Potency API Product Type, Application and Specification
6.8.2.1 Synthetic HPAPIs
6.8.2.2 Biotech HPAPIs
6.8.3 GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck & Co
6.9.2 High Potency API Product Type, Application and Specification
6.9.2.1 Synthetic HPAPIs
6.9.2.2 Biotech HPAPIs
6.9.3 Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 AbbVie
6.10.2 High Potency API Product Type, Application and Specification
6.10.2.1 Synthetic HPAPIs
6.10.2.2 Biotech HPAPIs
6.10.3 AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Mylan

7 High Potency API Manufacturing Cost Analysis
7.1 High Potency API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of High Potency API

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 High Potency API Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of High Potency API Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States High Potency API Market Forecast (2017-2022)
11.1 United States High Potency API Sales, Revenue Forecast (2017-2022)
11.2 United States High Potency API Sales Forecast by Type (2017-2022)
11.3 United States High Potency API Sales Forecast by Application (2017-2022)
11.4 High Potency API Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *